SecBot SecBot
SECBOTREPLAY Home › Report › FTH

FTH · Cambrian BioPharma Inc, a 10% stockholder of Faeth Therapeutics, filed…

Faeth Therapeutics, Inc. · 144 filed Aug 11, 2026 at 12:52 ET

At the news

BEARISHIMPACT 5/10

144 filed Aug 11, 2026 at 12:52 ET

Cambrian BioPharma Inc, a 10% stockholder of Faeth Therapeutics, filed a Form 144 notice of intent to sell 130,142 shares of common stock, with an estimated aggregate market value of approximately $3.64 million. The shares were acquired in a private placement in January 2020. This represents a notable insider selling signal from a major shareholder, though the sale is not yet executed and the filing is an advance notice of intent.

  • Cambrian BioPharma Inc, a 10% stockholder, filed a Form 144 to sell 130,142 shares of Faeth Therapeutics common stock.
  • The estimated aggregate market value of the proposed sale is approximately $3.64 million based on a 07/22/2026 trade date.
  • Shares were acquired in a private placement on 01/10/2020.
  • The filing date is 08/11/2026, and the sale is planned through Fidelity Brokerage Services LLC.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access